Member Info for Richob

Certainly more buys than sells and no doubt we will see some delayed buy trades later.

Also clear that investors with fewer shares have had a bit of a panic.

There are some weeks, this being one, where this isn't the time to panic but each to their own.

Time for a small top up.

What we do know is that the Trading Update is due "at the end of the month". Technically this is Friday (the 26th) but Monday the 1st also fits that description.

Can't see any reason not to have had this already unless there is something else to put in, so looking at today until and including Friday for something to appear.

Thoughts are BAMS with Bruker, CE marking with Mologic, Manufacturing partner(s) (Europe or Asia) but would actually like to see a Daewoong update.

Onwards Avacta

Agree, Choo, Choo.

Yesterday had to be about schools and the five week intervals. Schools because of the political and social pressures and the intervals to say that we are guided by the science.

I think our test is the rabbit out of the hat part for Boris.

Should find out in the not too distant.

All the best.

As we start to claw our way back up, I thought it was notable yesterday that there was no denial of the 5-10 minute aspect of the LFT.

Who knows what Avacta have been looking to improve, whether that be timings or variants, or whatever.

We might well be getting an LFT that is beyond even our expectations.

Happy to here other views on this aspect.

All the best.

I doubt that we are directly linked with this specific one but Daewoong seem determined on the therapy front;

https://www.companynewshq.com/coronavirus-news/why-did-daewoong-request-off-label-use-of-covid-19-treatment-candidate/

There is a reference to mesylate in a previous update from Avacta as some form of PDL-1 inhibitor but it isn't the mesylate mentioned here but who knows what Daewoong have asked us to work on.

Whilst we remain fixated on the LFTs, it is sometimes worth reflecting on the various avenues being pursued.

All the best.

Junior, just click on the trades button.

Very interesting.

A £197k buy has just gone through at 200p.

Not a delayed trade.

Somebody might just know something.

https://uk.finance.yahoo.com/news/adeptrix-closes-series-financing-commercialize-211600322.html

Note both the tie in with Bruker and the Affi-Bams annotation.

This particular one has been on sale at $1200, which is about £900 each.

Onwards Avacta

There are two on here at the minute. Mumbo Jumbo (appropriate name) and Starbright.

Looking for an entry point perhaps? Here's why:

Avacta will have two tests
Nasal first
Saliva second
DHSC a likely customer
Europe a likely customer
USA a likely customer

Thought you wanted to manufacture?

Saliva test not yet evaluated
Porton Down used the wrong samples on the first nasal test
Huff Post says second nasal test show excellent results
DHSC a potential customer

Join the dots.

Wildstar. I am.

All the best.

Just enjoy.

Is on at the House of Commons at 3pm on M9nday to announce "the plan".

He will mention tests there, well before the market closes.

Not all RNSs are at 7am.

Cave Exigo.

I reckon Huff Post have been told to reign back.

Try posting on social media about Avacta and see how long it stays on.

Politics is politics and the government need this.

All the best.

Perhaps BAMS and a therapy, urbansea?

All the best.

Seas The Future

Hope you have forgiven your son, Busybuilder.

All the best.

Looks like the comments section needs some better researched comments !

Top notch, Poirot, cousin of leewill.

All the best.

The front page is now:

Therapeutics
Diagnostics
Investors

Pretty sure it had Covid and not Investors yesterday but would be happy to have that confirmed by anybody else that looked yesterday.

All the best.